Clinical Context
We think this has broad domain relevance to NCCN-IPI for DLBCL.
Clinical Context
We think this has broad domain relevance to NCCN-IPI for DLBCL.
Clinical Context
We think this has broad domain relevance to NCCN-IPI for DLBCL.
NCCN-IPI: Enhanced granular scoring for DLBCL treated with immunochemotherapy.
Age at Diagnosis
Serum LDH (Normalized Ratio)
Total NCCN-IPI Score
Risk Category
Estimated 5-y Overall Survival: 96%
Verified
Last Review: 2026
Last Comprehensive Review: 2026
